BioCentury
ARTICLE | Company News

Agendia sales and marketing update

June 11, 2012 7:00 AM UTC

Agendia launched its colon cancer recurrence test ColoPrint for stage II colon cancer prognosis and prediction. ColoPrint is a microarray-based 18-gene expression profile. ...